BioSpace News Archive

Business

GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the appointment of Marissa Song as GRAIL’s General Counsel and Corporate Secretary, with responsibility for overseeing GRAIL’s legal and corporate compliance functions.

September 30, 2019
·
2 min read
Policy

Miller Law LLC, Hilliard & Shadowen LLP, Motley Rice LLC, and Cohen Milstein Sellers & Toll PLLC Announce Notice of Class Action for In re Loestrin 24 Fe Antitrust Litigation

If You Purchased Loestrin 24 Fe, Minastrin 24 Fe and/or Their Generic Equivalent(s) a Class Action Lawsuit May Affect Your Rights

September 30, 2019
·
3 min read
Policy

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MYGN

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Myriad Genetics, Inc. from September 2, 2016 through August 13, 2019, inclusive.

September 30, 2019
·
3 min read
Policy

MYGN Loss Alert: Hagens Berman Notifies Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit

Class-action law firm urges MYGN investors who have suffered losses of 50K+ to learn their shareholder rights

September 30, 2019
·
2 min read
Job Trends

Tried and True Technology Defines the Enterprise Healthcare Provider Compensation Software Market

ProCARE Portal brings proven Fortune 500 Incentive Compensation Management technology to healthcare to address the most complex physician compensation challenges

September 30, 2019
·
2 min read
Drug Development

Opdivo (nivolumab) Demonstrates Statistically Significant Overall Survival Benefit Versus Chemotherapy in Patients with Advanced Esophageal Cancer

Opdivo demonstrated a 23% reduction in the risk of death and 2.5-month improvement in median overall survival compared to chemotherapy

September 30, 2019
·
36 min read
BioMidwest

Attendees to Meet in Chicago for Neuroscience 2019: The Global Epicenter of Brain Science

Approximately 28,000 neuroscience researchers, clinicians, and advocates from around the world will gather in Chicago from October 19-23 for Neuroscience 2019, the Society for Neuroscience annual meeting.

September 30, 2019
·
2 min read
Drug Development

LYNPARZA (olaparib) More Than Doubled the Time Without Radiographic Disease Progression in Patients With BRCA1/2- or ATM-Mutated Metastatic Castration-Resistant Prostate Cancer

AstraZeneca and Merck’s LYNPARZA reduced the risk of disease progression or death by 51% in men with homologous recombination repair (HRR) gene mutations

September 30, 2019
·
18 min read
BioMidwest

Researchers Find Shorter Sleep Periods Associated with Obesity in African Americans

Minority Groups Susceptible to Becoming Overweight or Obese Not Included in Earlier Studies, According to Authors in The Journal of the American Osteopathic Association

September 30, 2019
·
2 min read
BioMidwest

AANA’s Simulation Room: The Latest in Arthroscopy Education

The Arthroscopy Association of North America (AANA) will debut the AANA J. Whit Ewing, M.D. Simulation Room in the Orthopaedic Learning Center (OLC) with a Ribbon-Cutting Ceremony Oct. 4.

September 30, 2019
·
2 min read